China News Service, August 9th. According to the website of the National Health and Health Commission, the General Office of the National Health and Health Commission and the Office of the State Administration of Traditional Chinese Medicine issued a notice on the 9th saying that according to the State Food and Drug Administration, azvudine tablets were approved to increase the treatment of new drugs. In order to further improve the antiviral treatment plan for new coronavirus pneumonia, the drug was included in the "New Coronavirus Pneumonia Diagnosis and Treatment Plan (Ninth Edition)" after research.
details as follows:
1. The name of the drug
Azvudine tablets.
2. Indications
For the treatment of adult patients with common novel coronavirus pneumonia (COVID-19).
3. Usage and dosage
Swallow whole tablet on an empty stomach, 5 mg each time, once a day, the course of treatment should not exceed 14 days.
4. Matters needing attention
It is not recommended for use during pregnancy and lactation, and it should be used with caution in patients with moderate to severe hepatic and renal impairment.
Before using this drug, you should read the "Azvudine Tablets Instructions" approved by the State Food and Drug Administration, and use the drug correctly according to the indications, usage and dosage specified in the instructions.
Patients should take medication under the guidance of a physician.
Before prescribing this drug, physicians should be familiar with the contraindications, adverse reactions, drug interactions, etc., and inquire about the patient's drug allergy history in detail, so as to avoid the use of patients with contraindications.
All localities must strictly follow the requirements of the "Administrative Measures for the Reporting and Monitoring of Adverse Drug Reaction", and do a good job in monitoring and reporting adverse drug reactions to ensure drug safety.